Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Personalized Intervention Program: Tobacco Treatment for Patients at Risk for Lung Cancer (PIP)

NCT02658032 is registered in ClinicalTrials.gov with Yale University as lead sponsor.

NCT NCT02658032
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02658032 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Personalized Intervention Program: Tobacco Treatment for Patients at Risk for Lung Cancer (PIP)
Lead sponsor
Yale University
Phase
Not applicable
Overall status
Completed
Start date
January 31, 2016
Completion date
October 31, 2020
Enrollment
276 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

biofeedback, smoking cessation